IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1027 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  
Resource Links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »  Article in PDF (184 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)

 
In This Article
 »  References

 Article Access Statistics
    Viewed2025    
    Printed76    
    Emailed1    
    PDF Downloaded124    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
 Table of Contents    
LETTER TO EDITOR
Year : 2011  |  Volume : 43  |  Issue : 1  |  Page : 94-95
 

The novelty of research article: Whose responsibility is it?


American University of Caribbean, School of Medicine, St. Maarten, Netherlands Antilles

Date of Web Publication15-Jan-2011

Correspondence Address:
Ravindra S Beedimani
American University of Caribbean, School of Medicine, St. Maarten, Netherlands Antilles

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.75689

Rights and Permissions



How to cite this article:
Beedimani RS. The novelty of research article: Whose responsibility is it?. Indian J Pharmacol 2011;43:94-5

How to cite this URL:
Beedimani RS. The novelty of research article: Whose responsibility is it?. Indian J Pharmacol [serial online] 2011 [cited 2021 Dec 6];43:94-5. Available from: https://www.ijp-online.com/text.asp?2011/43/1/94/75689


Sir,

I would like to comment on the article entitled "Effective control of sickle cell disease with hydroxyurea therapy" [1] published in Jan-Feb, 2010 issue of Indian Journal of Pharmacology. I have found nothing novel about the topic which makes it to be published. Any research article must meet certain criteria and standards that are set by the editorial and review committee before it can be published. That said, I saw nothing novel in the study, the main objective of which was the evaluation of hydroxyurea therapy in sickle cell patients. This has already been well studied and established for some time; [2],[3] indeed, this is referenced in the article itself and in standard pharmacology texts. [4],[5] In the 15 years that I have instructed undergraduate and postgraduate medical students in Pharmacology, I have routinely taught about the effectiveness and safety of hydroxyurea in the control of sickle cell disease. I would therefore enquire the authors and other concerned members about the criteria that merited publication of the article in the journal.

 
 » References Top

1.Singh H, Dulhani N, Kumar BN, Singh P, Tiwari P. Effective control of sickle cell disease with hydroxyurea therapy. Indian J Pharmacol 2010;42:32-5.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.Ware RE, Zimmerman SA, Schultz WH. Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood 1999;94:3022-6.  Back to cited text no. 2
[PUBMED]  [FULLTEXT]  
3.Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest 1984;74:652-6.  Back to cited text no. 3
[PUBMED]  [FULLTEXT]  
4.Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT, et al. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J Clin Invest 2003;111:231-9.  Back to cited text no. 4
[PUBMED]  [FULLTEXT]  
5.Franco RS, Yasin Z, Palascak MB, Ciraolo P, Joiner CH, Rucknagel DL. The effect of fetal hemoglobin on the survival characteristics of sickle cells. Blood 2006;108:1073-6.  Back to cited text no. 5
[PUBMED]  [FULLTEXT]  



This article has been cited by
1 Authorsę reply
Singh, H., Dulhani, N., Kumar, B.N., Singh, P., Tiwari, P.
Indian Journal of Pharmacology. 2011; 43(1): 95
[Pubmed]



 

Top
Print this article  Email this article
 

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow